MedDevNews, Q1 2021
Q1 2021 Saw Overall Growth in Transaction Activity
The rise in M&A activity and continued financing activity in Q1 was a function of improved buyer and investor optimism as patient volumes and surgical procedures began to rebound. Half of our tracked sectors in the medical device space witnessed positive stock price momentum against the S&P 500, which brings greater access to financing options and boosts appetites for M&A.
